Device Trial Radar · NCT02769273
Stellarex Vascular E-Registry
Last checked: Nov 19, 2026Latest source record: Aug 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,900
Actual
Start
Jun 2016
Primary completion
Oct 31, 2021
Study completion Dec 2021
Sponsor
- Lead sponsor
- Spectranetics CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 11, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, international, multi-center, single arm, observational study to continue to assess the treatment by the Stellarex™ OTW Drug-coated Angioplasty Balloon in superficial femoral and/or popliteal arteries according to the Instructions for Use in a broad, real-world, claudicant or ischemic rest pain patients population per the institution's standard practice.
Conditions
- Peripheral Arterial Disease
Interventions
Percutaneous Transluminal AngioplastyDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Efficacy Endpoint Cohort 1 - RCC 2-3:Time frame: 12 months post-procedure
- Primary Safety Endpoint-Cohort 1 - RCC 2-3Time frame: 30 days post-procedure - 12Month post procedure
- Primary effectiveness endpoint: Cohort 2 - RCC 4-6 (CLI)Time frame: 6 Months post procedure
1 more outcomes with a free account
Locations
46 sites in 6 countries. Site status is shown where the registry gives one.
Medical University Graz
Graz, Austria
Krankenhaus der Barmherzigen Schwesterrn Reid
Ried im Innkreis, Austria
Krankenhaus Göttlicher Heiland GmbH
Vienna, Austria
43 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.